FY2025 SEC EDGAR DEF 14A #96 of 168 in industry

Geron Corp CEO pay ratio

The CEO earned $315K in FY2025 against median worker pay of $8,995 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-07
Industry
Chemicals & Pharmaceuticals
Industry rank
#96/168

Data updated August 2026

Subscribe to Geron Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
35:1
Below Average (Scale: 0–1000:1)
CEO pay
$315K
Median worker
$8,995

Answer first

Geron Corp's FY2025 CEO total of $315K ranks #1307 of 1,423 complete filings; its 35:1 pay ratio ranks #1110. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $8,995. Industry placement uses the FY2025 SIC-28 peer cohort (# 96 of 168, 43rd percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1307
$315K of 1,423 FY2025
Ratio rank
#1110
35:1 of 1,423
Industry pct
43rd
below the industry median pay ratio

How Geron Corp ranks nationally

Geron Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$314,826 8th percentile higher than 8% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Geron Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($315K) against pay ratio (35:1) for Geron Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both04601554.09203107.913804661.918406215.933.6:135.8:138:140.2:142.4:1CEO total payPay ratio (CEO : median worker)Geron Corp, CEO total pay: 314826 · Pay ratio (CEO : median worker): 35:1Geron CorpEvolus, Inc., CEO total pay: 6412214 · Pay ratio (CEO : median worker): 35:1Evolus, Inc.Kiniksa Pharmaceuticals International, plc, CEO total pay: 310707 · Pay ratio (CEO : median worker): 35:1Kiniksa Pharmaceuticals International, plcPrecigen, Inc., CEO total pay: 5354329 · Pay ratio (CEO : median worker): 34:1Precigen, Inc.Rhythm Pharmaceuticals, Inc., CEO total pay: 17544525 · Pay ratio (CEO : median worker): 36:1Rhythm Pharmaceuticals, Inc.Cryoport, Inc., CEO total pay: 2392161 · Pay ratio (CEO : median worker): 37:1Cryoport, Inc.
Geron Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Geron Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Geron Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
35:1
FY2025
vs prior FY
+20:1
from FY2024 15:1
CEO $ YoY
-95%
$315K latest
Filings shown
3
FY2021–2025
Geron Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $2.1M - $460,336 5:1 -
2024 $6.1M +198% $408,349 15:1 +10:1
2025 $315K -95% $8,995 35:1 +20:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 886744, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
35:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$315K
Companies in Industry
168
vs. Industry Median
Below
#96 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Geron Corp: MODEST · MICRO pay ratio

Geron Corp's FY2025 CEO total $315K ranks #1307 of 1,423 complete filings (lower third by dollars). the CEO earned 35× the median employee ($8,995) in FY2025.

Median employee $8,995 (LOW-MED); MODEST · MICRO stamps put about 35 median-wage years per CEO year.

CEO Total Pay

$315K

FY2025 Summary Compensation, below median

Pay Ratio

35:1

Below typical

Geron Corp in the lower-dollar third

Geron Corp's FY2025 CEO total $315K ranks #1307 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Geron Corp's $315K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1307 and ratio rank #1110 split - treat 35:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$315K
Median Employee Pay
$8,995
Pay Ratio
35:1
Filing Date
2026-04-07

Company Info

CIK
886744
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 886744, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Geron Corp's FY2025 CEO total $315K ranks #1307 of 1,423 complete filings (lower third by dollars).

Read with Geron Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · LOW-MED.

Grand Canyon Education, Inc. · MICRO

ABS(ceo_total_comp) peer at $311K (Δ $4K lighter vs Geron Corp); FLOOR · PAR-MED vs this page's MODEST · MICRO · LOW-MED.
Aurinia Pharmaceuticals Inc. · MICRO

ABS(ceo_total_comp) peer at $320K (Δ $5K heavier vs Geron Corp); FLOOR · ELITE-MED vs this page's MODEST · MICRO · LOW-MED.
Burford Capital Ltd · MICRO

ABS(ceo_total_comp) peer at $309K (Δ $6K lighter vs Geron Corp); MODEST · ELITE-MED vs this page's MODEST · MICRO · LOW-MED.
Alexanders Inc · MICRO

ABS(ceo_total_comp) peer at $321K (Δ $6K heavier vs Geron Corp); FLOOR · HIGH-MED vs this page's MODEST · MICRO · LOW-MED.
Evolus, Inc. (SIC 28 pole)

Evolus, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Geron Corp's MODEST filing.
National dual ranks · #1307/#1110

Geron Corp's FY2025 package sits #1307 by CEO dollars and #1110 by ratio under MICRO · MODEST.
Ratio primer · MODEST

Geron Corp's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Geron Corp (CIK 886744), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.